× The internal search function is temporarily non-functional. The current search engine is no longer viable and we are researching alternatives.
As a stop gap measure, we are using Google's custom search engine service.
If you know of an easy to use, open source, search engine ... please contact support@midrange.com.


  • Subject: Demise of V3R2 & V3R7 Support
  • From: bvining@xxxxxxxxxxxx
  • Date: Mon, 16 Feb 98 09:32:59 CST

But the previous date for withdrawal of service was October 31 1998
(in the V3R2 original announcement letter 296-184 dated June 4 1996).
I see this as extending the support cycle 17 months for V3R2, and to
be of distinct value to V3R2 users.

Bruce Vining

>
>Is it  just me or is this rather $hort cycled support period and  very
>untimely
>
>>>Monday Morning AS/400 Update - February 16, 1998
>
>V3R2/V3R7 Service Termination. IBM put everyone on notice
>that effective May 31, 2000, it will end program services
>for OS/400 V3R2 and most V3R2 licensed programs. This means
>that IBM will cease all product defect resolution services.
>Clearly, the company is encouraging everyone to upgrade to
>RISC systems running Version 4 or above by that date. As for
>V3R7, IBM is ending program services on June 30, 1999. If
>you're running V3R7, I'd advise you to move to V4 by that
>date. For more details, see Announcement Letter #298-030.<<
>
>Oh well just  another thing to do before 2000.
>
>CISC  & V3  are to  die  by the turn of the Century <<?>>

+---
| This is the Midrange System Mailing List!
| To submit a new message, send your mail to "MIDRANGE-L@midrange.com".
| To unsubscribe from this list send email to MIDRANGE-L-UNSUB@midrange.com.
| Questions should be directed to the list owner/operator: david@midrange.com
+---


As an Amazon Associate we earn from qualifying purchases.

This thread ...


Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2024 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].

Operating expenses for this site are earned using the Amazon Associate program and Google Adsense.